1. Home
  2. MESO vs PLAB Comparison

MESO vs PLAB Comparison

Compare MESO & PLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mesoblast Limited

MESO

Mesoblast Limited

N/A

Current Price

$13.68

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Logo Photronics Inc.

PLAB

Photronics Inc.

N/A

Current Price

$28.96

Market Cap

1.7B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
MESO
PLAB
Founded
2004
1969
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
2005
1995

Fundamental Metrics

Financial Performance
Metric
MESO
PLAB
Price
$13.68
$28.96
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$37.00
★ $41.33
AVG Volume (30 Days)
255.3K
★ 794.9K
Earning Date
08-26-2026
12-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 9.09
EPS
N/A
★ 1.76
Revenue
N/A
★ $535,276,000.00
Revenue This Year
$51.63
$2.20
Revenue Next Year
$63.39
$2.81
P/E Ratio
★ N/A
$16.44
Revenue Growth
N/A
★ 18.77
52 Week Low
$11.89
$20.05
52 Week High
$21.50
$56.00

Technical Indicators

Market Signals
Indicator
MESO
PLAB
Relative Strength Index (RSI) 46.52 52.25
Support Level $11.89 $27.37
Resistance Level $16.03 $29.89
Average True Range (ATR) 0.50 1.22
MACD 0.07 0.12
Stochastic Oscillator 40.72 82.14

Price Performance

Historical Comparison
MESO
PLAB

About MESO Mesoblast Limited

Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company principally engaged in the manufacturing of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of integrated circuits (ICs) and flat-panel displays (FPDs) and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during fabrication, as well as to a lesser extent, other types of electrical and optical components. The Company has manufacturing facilities in Taiwan, China, South Korea, the United States, and Europe, and generates revenue globally, with Taiwan contributing the majority of total revenue.

Share on Social Networks: